Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal oxytocin versus promestriene for genitourinary syndrome of menopause
RBR-2gvk3dCompleted
- Sponsor
- Federal University of São Paulo
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in vaginal atrophy and atrophic vaginitis comparing Vaginal oxytocin with Vaginal promestriene (2 arms). Started Sep 2018; status: completed.
02
Drugs
oxytocinpromestriene
03
Conditions
vaginal atrophyatrophic vaginitis
Beyond the preview
Go deeper on RBR-2gvk3d.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2gvk3d.